November 14, 2016
On November 13th, ASBM conducted a 5-hour Continuing Education (CE) course for 100 New York pharmacists in Queens, NY. The course, entitled “Biosimilars and Biologics- Regulatory and Practice Issues for Pharmacists” was presented in conjunction with the Long Island University College of Pharmacy (LIU-Pharmacy). The course was a follow-up to the 5-hour course ASBM and LIU-Pharmacy presented in March […]
September 15, 2016
On September 15th, 2016, ASBM held an educational forum at the University of the Sciences in Philadelphia (USciences). The program drew 50 attendees comprised of pharmacists, faculty members, pharmacy students. The program began with an introduction to biosimilars from USciences Associate Professor of Pharmaceutical Sciences Dr. Zhiyu Li. Dr. Li is Director of Undergraduate Pharmacology/Toxicology Program, where he […]
July 25, 2016
On Friday, July 22nd, The Alliance for Safe Biologic Medicines and MedChi, the Maryland State Medical Society co-hosted a forum entitled “Biosimilars: New Choices, New Challenges”. The event was attended by more than 45 physicians, legislators, patient advocates, healthcare workers, and others. MedChi’s CEO, Gene Ransom III began the forum with a discussion of the importance of biosimilars […]
July 25, 2016
On Friday, July 22nd, The Alliance for Safe Biologic Medicines and MedChi, the Maryland State Medical Society co-hosted a forum entitled “Biosimilars: New Choices, New Challenges”. The event was attended by more than 45 physicians, legislators, patient advocates, healthcare workers, and others. MedChi’s CEO, Gene Ransom III began the forum with a discussion of the importance of biosimilars […]
July 6, 2016
ASBM was an exhibitor during the 52nd Annual meeting of the Drug Information Association (DIA) held June 26th-30th in Philadelphia. ASBM members and staff discussed biosimilars policy with attendees, including the need for the FDA to maintain high standards for safety and efficacy when approving biosimilars. More than 65 attendees, including clinical researchers, physicians, pharmacists, […]
May 12, 2016
On May 10th, ASBM cohosted an educational briefing on biosimilars with the Ohio State University College of Medicine at the University’s Wexner Medical Center in Columbus, OH. The audience was comprised of a broad cross section of stakeholders including patient advocates, physicians, pharmacists, representatives from the Ohio Pharmacy Association, The Ohio Nurses Association, a State Representative, medical […]
April 15, 2016
On April 12th, in Geneva, Switzerland, ASBM President Doug Badger and Advisory Board Chair Philip Schneider, MS, FASHP presented to the World Health Organization as part of its 62nd International Nonproprietary Name (INN) Consultation.
April 15, 2016
On April 12th, in Geneva, Switzerland, ASBM President Doug Badger and Advisory Board Chair Philip Schneider, MS, FASHP presented to the World Health Organization as part of its 62nd International Nonproprietary Name (INN) Consultation.
June 18, 2015
The Alliance for Safe Biologic Medicines (ASBM) today presented at the 51st Annual Meeting of the Drug Information Association (DIA). Physician data regarding biosimilars was shared from five surveys and eleven countries, including for the first time the results of ASBM’s recent survey of Latin American physicians.
